Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice : Identification of risk factors and the role of prophylaxis / G. Caocci, O. Mulas, M. Annunziata, L. Luciano, M. Bonifacio, E.M. Orlandi, P. Pregno, S. Galimberti, A. Russo Rossi, E. Abruzzese, A. Iurlo, B. Martino, N. Sgherza, G. Binotto, F. Castagnetti, A. Gozzini, C. Fozza, M. Bocchia, A. Sicuranza, F. Stagno, F. Efficace, E. Usala, F. De Gregorio, L. Scaffidi, C. Elena, F. Pirillo, C. Barate, M.M. Trawinska, D. Cattaneo, C. Labate, G. Gugliotta, M. Molica, G. Specchia, G. La Nasa, R. Foa, M. Breccia. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 0361-8609. - 93:7(2018 Jul), pp. E159-E161. [10.1002/ajh.25102]
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice : Identification of risk factors and the role of prophylaxis
D. Cattaneo;
2018
File | Dimensione | Formato | |
---|---|---|---|
Caocci G et al. Am J Hematol 2018.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
1.18 MB
Formato
Adobe PDF
|
1.18 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.